alexa
Reach Us +44-1904-929220
Thromboxane Synthase: A Biomarker For Targeting Therapy Of Non-small Cell Lung Carcinoma | 8929
ISSN-2155-9929

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Thromboxane synthase: A biomarker for targeting therapy of non-small cell lung carcinoma

4th International Conference on Biomarkers & Clinical Research

George G. Chen, Yi Liu, Run-Yue Huang, Ming-Yue Li, Innes Y.P Wan, Calvin SH Ng and Malcolm J. Underwood

AcceptedAbstracts: J Mol Biomark Diagn

DOI: 10.4172/2155-9929.S1.019

Abstract
T hromboxane synthase (TXS) converts prostaglandin H 2 to thromboxane A 2 (TXA 2 ). The role of TXS or TXA 2 in tumor growth and metastasis has been documented in a number of cancers. However, their pathways and significance are not fully understood, and furthermore, limited information is available in non-small cell lung carcinoma (NSCLC). Using NSCLC cell lines and mouse lung tumor models, we determined the levels of TXS and TXB2 (a stable metabolite of TXA2) and explored signal transduction pathway of TXS in NSCLC. It was found that the level of TXB2 was significantly increased in NSCLC, especially those who smoke. Using cigarette smoking carcinogen 4-methylnitrosamino-1-3-pyridyl-1-butanone (NNK), we demonstrated that NNK could stimulate the expression of TXS to produce a significant amount of TXB2. The significance of TXS/TXA2 in smoking-induced lung cancer was further demonstrated in A/J mice treated with NNK as the level of TXS was significantly higher than the control. Importantly, the inhibition of TXS led to a marked increase in the death of NSCLC cells via inducing apoptosis. The apoptosis induced by the inhibition of TXS was associated with the reduction of nuclear factor kappaB but the enhancement of the nuclear p27. The block of p27 by its siRNA partially but significantly recovered the apoptosis induced by TXS inhibitors. TXS-mediated apoptosis was also found to be related to PI3K/Akt but not JNK and p38 pathways. In summary, NSCLC is associated with the expression of TXS that is at least in part attributable to cigarette smoking. The inhibition of TXS can arrest the growth of NSCLC cells by inducing apoptosis, making TXS a potential therapeutic target
Biography
George G. Chen had medical training in China and Ph.D. and postdoctoral training in United Kingdom. Currently, he is a Professor at Department of Surgery, Faculty of Medicine, the Chinese University of Hong Kong, and he is also the director of Surgical Laboratories at the same institute. He has published more than 180 papers in peer-reviewed journals and served several journals as a board member
Relevant Topics
Top